학술논문
Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial
Document Type
Article
Author
Source
In The Lancet Diabetes & Endocrinology February 2023 11(2):86-95
Subject
Language
ISSN
2213-8587